Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration

PaperCitations, authors & open-access status

Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 22 citations, 2018 year and closed oa status.

22
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Sherry Shi
Author
Bladder and Urothelial Cancer Treatments
Topic
Bladder and Urothelial Cancer Treatments
Topic
Renal cell carcinoma treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account